BACKGROUND AND OBJECTIVES: Infantile nephropathic cystinosis is a severe disease that occurs due to mutations in the cystinosis gene, and it is characterized by progressive dysfunction of multiple organs; >100 cystinosis gene mutations have been identified in multiple populations. Our study aimed to identify the clinical characteristics and spectrum of cystinosis gene mutations in Turkish pediatric patients with cystinosis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We identified the clinical characteristics and spectrum of cystinosis gene mutations in Turkish patients with cystinosis in a multicenter registry that was established for data collection. The data were extracted from this registry and analyzed. RESULTS: In total, 136 patients (75 men and 61 women) were enrolled in the study. The most common clinical findings were growth retardation, polyuria, and loss of appetite. None of the patients had the 57-kb deletion, but seven novel mutations were identified. The most common mutations identified were c.681G>A (p.Glu227Glu; 31%), c.1015G>A (p.Gly339Arg; 22%), and c.18_21 del (p.Thr7Phefs*7; 14%). These mutations were associated with earlier age of disease onset than the other mutations. To understand the effects of these allelic variants on clinical progression, the mutations were categorized into two major groups (missense versus deletion/duplication/splice site). Although patients with missense mutations had a better eGFR at the last follow-up visit, the difference was not significant. Patients in whom treatment began at age <2 years old had later onset of ESRD (P=0.02). Time to ESRD did not differ between the patients with group 1 and group 2 mutations. CONCLUSIONS: The most common cystinosis gene mutations identified in Turkey were c.681G>A (p.Glu227Glu), c.1015G>A (p.Gly339Arg), and c.18_21 del (p.Thr7Phefs*7). Patients with less severe cystinosis gene mutations tend to have better kidney outcome.
BACKGROUND AND OBJECTIVES: Infantile nephropathic cystinosis is a severe disease that occurs due to mutations in the cystinosis gene, and it is characterized by progressive dysfunction of multiple organs; >100 cystinosis gene mutations have been identified in multiple populations. Our study aimed to identify the clinical characteristics and spectrum of cystinosis gene mutations in Turkish pediatric patients with cystinosis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We identified the clinical characteristics and spectrum of cystinosis gene mutations in Turkish patients with cystinosis in a multicenter registry that was established for data collection. The data were extracted from this registry and analyzed. RESULTS: In total, 136 patients (75 men and 61 women) were enrolled in the study. The most common clinical findings were growth retardation, polyuria, and loss of appetite. None of the patients had the 57-kb deletion, but seven novel mutations were identified. The most common mutations identified were c.681G>A (p.Glu227Glu; 31%), c.1015G>A (p.Gly339Arg; 22%), and c.18_21 del (p.Thr7Phefs*7; 14%). These mutations were associated with earlier age of disease onset than the other mutations. To understand the effects of these allelic variants on clinical progression, the mutations were categorized into two major groups (missense versus deletion/duplication/splice site). Although patients with missense mutations had a better eGFR at the last follow-up visit, the difference was not significant. Patients in whom treatment began at age <2 years old had later onset of ESRD (P=0.02). Time to ESRD did not differ between the patients with group 1 and group 2 mutations. CONCLUSIONS: The most common cystinosis gene mutations identified in Turkey were c.681G>A (p.Glu227Glu), c.1015G>A (p.Gly339Arg), and c.18_21 del (p.Thr7Phefs*7). Patients with less severe cystinosis gene mutations tend to have better kidney outcome.
Authors: Martine T P Besouw; Maria Van Dyck; Inge Francois; Elke Van Hoyweghen; Elena N Levtchenko Journal: Pediatr Nephrol Date: 2012-06-05 Impact factor: 3.714
Authors: Neveen A Soliman; Mohamed A Elmonem; Lambertus van den Heuvel; Rehab H Abdel Hamid; Mohamed Gamal; Inge Bongaers; Sandrine Marie; Elena Levtchenko Journal: JIMD Rep Date: 2014-01-25
Authors: V Shotelersuk; D Larson; Y Anikster; G McDowell; R Lemons; I Bernardini; J Guo; J Thoene; W A Gahl Journal: Am J Hum Genet Date: 1998-11 Impact factor: 11.025
Authors: Michael Kiehntopf; Jörg Schickel; Bärbel von der Gönne; Hans Georg Koch; Andrea Superti-Furga; Beat Steinmann; Thomas Deufel; Erik Harms Journal: Hum Mutat Date: 2002-09 Impact factor: 4.878
Authors: Vasiliki Kalatzis; Lola Cohen-Solal; Béatrice Cordier; Yaacov Frishberg; Markus Kemper; E Matti Nuutinen; Eric Legrand; Pierre Cochat; Corinne Antignac Journal: Hum Mutat Date: 2002-12 Impact factor: 4.878
Authors: Mohammed A Aldahmesh; Amal Humeidan; Hamad A Almojalli; Arif O Khan; Mohammed Rajab; Abbas A AL-Abbad; Brian F Meyer; Fowzan S Alkuraya Journal: Ophthalmic Genet Date: 2009-12 Impact factor: 1.803
Authors: Nina O'Connell; Jun Oh; Klaus Arbeiter; Anja Büscher; Dieter Haffner; Jessica Kaufeld; Christine Kurschat; Christoph Mache; Dominik Müller; Ludwig Patzer; Lutz T Weber; Burkhard Tönshoff; Marcus Weitz; Katharina Hohenfellner; Lars Pape Journal: Front Med (Lausanne) Date: 2022-04-25